N, N., F, O., H, O., Y, N., & N, K. (2018). Design of a transdermal formulation containing raloxifene nanoparticles for osteoporosis treatment. Dove Medical Press.
Style de citation Chicago (17e éd.)N, Nagai, Ogata F, Otake H, Nakazawa Y, et Kawasaki N. Design of a Transdermal Formulation Containing Raloxifene Nanoparticles for Osteoporosis Treatment. Dove Medical Press, 2018.
Style de citation MLA (8e éd.)N, Nagai, et al. Design of a Transdermal Formulation Containing Raloxifene Nanoparticles for Osteoporosis Treatment. Dove Medical Press, 2018.
Attention : ces citations peuvent ne pas être correctes à 100%.